Pharsight

1. Korsuva patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US10793596	CARA THERAP	Synthetic peptide amides	Nov, 2027 (4 years from now)
US10017536	CARA THERAP	Synthetic peptide amides and dimers thereof	Nov, 2027 (4 years from now)
US8536131	CARA THERAP	Synthetic peptide amides and dimers thereof	Nov, 2027 (4 years from now)
US7727963	CARA THERAP	Synthetic peptide amides	Nov, 2027 (4 years from now)
US7713937	CARA THERAP	Synthetic peptide amides and dimeric forms thereof	Nov, 2027 (4 years from now)
US7402564	CARA THERAP	Synthetic peptide amides	Nov, 2027 (4 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9359399	CARA THERAP	Synthetic peptide amides	Nov, 2027 (4 years from now)
US10138270	CARA THERAP	Synthetic peptide amides	Nov, 2027 (4 years from now)
US9334305	CARA THERAP	Synthetic peptide amides and dimers thereof	Nov, 2027 (4 years from now)
US8486894	CARA THERAP	Synthetic peptide amides and dimeric forms thereof	Nov, 2027 (4 years from now)
US8236766	CARA THERAP	Uses of synthetic peptide amides	Nov, 2027 (4 years from now)
US8217007	CARA THERAP	Synthetic peptide amides	Nov, 2027 (4 years from now)